Invention Grant
- Patent Title: Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection
- Patent Title (中): 二氢喹诺酮用于治疗和预防乙型肝炎病毒感染
-
Application No.: US14610454Application Date: 2015-01-30
-
Publication No.: US09458153B2Publication Date: 2016-10-04
- Inventor: Xingchun Han , Hassan Javanbakht , Min Jiang , Chungen Liang , Jianping Wang , Yongguang Wang , Zhanguo Wang , Robert James Weikert , Song Yang , Chengang Zhou
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Little Falls
- Assignee: Hoffmann-La Roche INC.
- Current Assignee: Hoffmann-La Roche INC.
- Current Assignee Address: US NJ Little Falls
- Agent Jonathan Duffield
- Priority: CNPCT/CN2014/071854 20140130; CNPCT/CN2014/094206 20141218
- Main IPC: C07D455/06
- IPC: C07D455/06 ; C07D471/04
Abstract:
The invention provides novel compounds having the general formula: wherein R1, R2, R3, R4, R5 and R6 are as described herein, compositions including the compounds and methods of using the compounds.
Public/Granted literature
- US20160207914A9 Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection Public/Granted day:2016-07-21
Information query
